| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.0M | — | +37.2% |
| Cost of Revenue | $395K | — | -21.9% |
| R&D Expense | $15.7M | — | +35.2% |
| SG&A Expense | $6.7M | — | +9.8% |
| Operating Income | -$22.2M | — | -22.7% |
| Net Income | -$19.8M | — | -31.4% |
| EPS (Basic) | -$0.15 | — | -25.0% |
| EPS (Diluted) | -$0.15 | — | -25.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $28.7M | +43.6% | -5.6% |
| Current Assets | $110.2M | +14.4% | +1.3% |
| Total Assets | $198.7M | +23.8% | +0.3% |
| Current Liabilities | $27.4M | -4.5% | +27.2% |
| Total Liabilities | $55.1M | -4.0% | +1.9% |
| Stockholders' Equity | $143.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.1M | — | -39.0% |
| Capital Expenditures | $13K | — | -69.8% |
| Investing Cash Flow | -$30.9M | — | -261.8% |
| Financing Cash Flow | $57.8M | — | — |
| Free Cash Flow | -$18.2M | — | -38.6% |
| -0.3% |